Filtrar por Last updated date SelectDespués deAntes deFrom - To Fecha Fecha de final Esta semana Este mes la semana pasada El mes pasado Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Deje este campo en blanco Filter Resultados (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Deje este campo en blanco EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG 12 Octubre 2021 News Human COVID-19 Vaccines A global approach to regulatory flexibility to increase manufacturing capacity during COVID-19 12 Octubre 2021 News Human COVID-19 Medicines Vaccines EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19 11 Octubre 2021 News Human COVID-19 Paediatrics Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 5-7 October 2021 8 Octubre 2021 News Veterinary Medicines Highlights of Management Board – October 2021 meeting 8 Octubre 2021 News Corporate Additional manufacturing site for COVID-19 Vaccine Janssen 7 Octubre 2021 News Human COVID-19 Comirnaty and Spikevax: EMA recommendations on extra doses and boosters 4 Octubre 2021 News Human COVID-19 EMA receives application for marketing authorisation for Regkirona (regdanvimab) for treating patients with COVID-19 4 Octubre 2021 News Human COVID-19 Medicines EMA welcomes new Head of International Affairs 1 Octubre 2021 News Corporate Careers Governance EMA starts review of meningioma risk with nomegestrol- and chlormadinone-containing medicines 1 Octubre 2021 News Human Pharmacovigilance Referrals 1 … 53 54 55 56 57 Page 57 of 380 58 59 60 61 … 380
EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG 12 Octubre 2021 News Human COVID-19 Vaccines
A global approach to regulatory flexibility to increase manufacturing capacity during COVID-19 12 Octubre 2021 News Human COVID-19 Medicines Vaccines
EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19 11 Octubre 2021 News Human COVID-19 Paediatrics
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 5-7 October 2021 8 Octubre 2021 News Veterinary Medicines
Comirnaty and Spikevax: EMA recommendations on extra doses and boosters 4 Octubre 2021 News Human COVID-19
EMA receives application for marketing authorisation for Regkirona (regdanvimab) for treating patients with COVID-19 4 Octubre 2021 News Human COVID-19 Medicines
EMA starts review of meningioma risk with nomegestrol- and chlormadinone-containing medicines 1 Octubre 2021 News Human Pharmacovigilance Referrals